Navigation Links
Fears of promiscuity pose barrier to cervical cancer vaccinations

The public's concerns about costs and increased promiscuity among teenagers appear to be hindering use of a vaccine against the human papilloma virus (HPV) to prevent life-threatening diseases, according to a study by researchers at Yale School of Public Health.

There is an ongoing public health campaign promoting the vaccination of girls against HPV to prevent against genital warts and cervical cancer, but the Yale study showed the public believes that the benefits are outweighed by potential disadvantages. The Yale researchersSanjay Basu, a Ph.D. candidate, and Alison Galvani, assistant professor in the Division of Epidemiology of Microbial Diseases studied how concerns about adolescent promiscuity and everyday economics lead many parents and guardians to not have their children treated.

The vast majority of those surveyed believed the risk of cervical cancer and genital warts (which are largely spread through sexual contact) is far lower with the HPV vaccine. But the same group of 326 adults in the United States also thought adolescent sexual activity would nearly double among those receiving the vaccine. Concern about increased promiscuity was the single biggest factor in the decision not to vaccinate, according to the study.

The Centers for Disease Control and Prevention recommends the HPV vaccination be administered to young girls between 11- and 12-years-old (and also to administer catch-up vaccinations to young women ranging from 13- to 26-years-old). But currently less than 25 percent of the target population has received even one of the three recommended vaccinations, far below the target needed to maximize the vaccine's potential public health benefit. An estimated 11,000 women in the United States alone were diagnosed in 2007 with invasive cervical cancer.

The researchers applied "game theory" to create a mathematical model of how such external factors as a fear of encouraging promiscuity and money influence perceptions and ultimately affect public health goals.

According to Basu and Galvani, the study suggests that educational programs that address specific public concerns might be needed to convince parents that the vaccine's benefits outweigh other factors.

In the past, other health campaigns have been hampered by the public's unwillingness to participate in sufficient numbers. "A fundamental but often-neglected aspect of developing and implementing an optimal intervention program is human psychology, which influences adherence to recommendations," Galvani said.

Financial considerations also influenced people's choices. The research found that even with health insurance and other financial assistance, the average family still had to spend $181 out of pocket to provide a child with all three vaccinations. The researchers estimated that the price of each vaccination would have to be cut by $55 per dose to significantly influence decision making in favor of the vaccine.

Even if an individual's perception on an issue such as HPV vaccination is not rational or well-informed, it is still a major factor in the decision-making process, the researchers said. If negative perceptions are widely held, they added, the effectiveness of a public health campaign could be crippled.


Contact: Karen N. Peart
Yale University

Related medicine news :

1. Easter Seals Study Sheds New Light on Parents Life-Long Fears, Anxieties and Critical Supports Needed to Raise a Child With Autism
2. Study finds fears of HIV transmission in families with infected parent
3. African American-Owned Condom Company Fears the Widening AIDS Epidemic
4. Genes Influence on Fears Changes Over Time
5. Interview by Internet Can Decrease Greatest End-of-Life Fears: It Facilitates Creating Effective Advance Directives, Living Wills
6. Most Cancer Survivors Say Chemo Fears Unfounded
7. Colonoscopy fears overcome when patients support patients
8. National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline
9. Barriers to Good Asthma Care Detailed
10. New Acticoat(TM) Silver Coated Anti-microbial Barrier Dressing Receives Regulatory Approval from Health Canada
11. Health-care barriers for undocumented immigrants: Raising tuberculosis risk?
Post Your Comments:
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
Breaking Medicine Technology: